Financial News · Live Terminal

Page 247 of 843

Tianqi Lithium Reports Fire at Talison Processing Plant in Australia

Tianqi Lithium (HKG:9696, SHE:002466) said a localized fire occurred at Chemical-Grade Lithium Concentrate Plant No. 3 in Australia operated by its subsidiary Talison Lithium during a maintenance shutdown, according to a Wednesday Hong Kong bourse filing.The company said the fire was promptly extinguished and all personnel were safely evacuated, with no injuries reported.Certain equipment was damaged, while major equipment and production lines were unaffected.Tianqi said the incident may affect the ramp-up of Plant No. 3, which began commissioning in December 2025 and produced its first batch of qualified chemical-grade lithium concentrate in January.The extent of the impact is still being assessed, the filing added.

HKG:9696SHE:002466

Asia28d ago

Hanwha Solutions Unit Begins Solar Cells Production at US Facility

Hanwha Solutions (KRX:009830) subsidiary Hanwha Qcells began producing solar cells at its Cartersville facility in Georgia, from Tuesday, the company said in a Thursday release.The solar manufacturer plans to increase cell production capacity to 3.3 gigawatts, the facility's full capacity, by the third quarter. Along with commencing solar cell production, the Cartersville module assembly is now at full capacity, building 16,700 panels a day.The plant will also manufacture wafers and ingots that are used in solar cell manufacturing, and 3.5 GW of modules a year. Combined with the company's Dalton, Georgia, facility, Hanwha Qcells' annual solar panel production capacity will reach 8.6 GW, it said.Shares of Hanwha Solutions fell over 2% in recent trade.

KRX:009830

Asia28d ago

Reece's Hiring Acceleration Point to Volume Growth, Jarden Says

Reece's (ASX:REH) acceleration of hiring, especially in specific roles, pointed to volume growth, with total active Reece job advertisements rising 27.9% since Jan. 5, Jarden said in a Wednesday note.Jarden said it analyzed pricing, job advertisement, website traffic, and footfall data across over 500 Reece Australian stores. Average prices across the over 2,000 stock-keeping units are up 6.3% since January, yet there is no evidence of volume elasticity.Footfall growth across the network has accelerated, up 8.4% year-to-date. In aggregate, 834 articles saw price increases year-to-date.Reece saw footfall data from Victoria inflecting from a 6.6% footfall decline through 2025 to 12.4% growth year-to-date.The investment firm retained its overweight rating on Reece and cut the price target to AU$16.10 per share from AU$16.40 per share.

ASX:REH

Asia28d ago

Larvotto Resources Enters Into Scheme Implementation Deed to Acquire Hammer Metals

Larvotto Resources (ASX:LRV) entered into a binding scheme implementation deed to acquire all the shares of Hammer Metals (ASX:HMX) through a scheme of arrangement, according to a Thursday filing with the Australian bourse.Hammer Metals shareholders will receive one new Larvotto share for every 22 Hammer shares held at the scheme record date, the filing said.After implementation of the scheme, Larvotto shareholders and Hammer Metals shareholders are expected to own about 92.7% and 7.3%, respectively, of the combined entity.The board of Hammer Metals unanimously recommended that shareholders vote in favor of the scheme, provided there is no superior proposal and the independent expert continues to conclude that the scheme is in the best interest of shareholders, per the filing.

ASX:HMXASX:LRV

Asia28d ago

Steadfast Group's Potential Acquisition by Amwins-Dragoneer Consortium Would Be at Cyclically Depressed Multiple, Jarden Says

Steadfast Group's (ASX:SDF) potential acquisition by the Amwins-Dragoneer consortium means the consortium would be capturing Steadfast at a cyclically depressed multiple even with the large headline premium, Jarden said in a Wednesday note.The company confirmed a conditional, non-binding indicative proposal from a consortium of Amwins and Dragoneer, Amwins' largest shareholder, to acquire 100% of Steadfast at AU$6 cash per share via a scheme of arrangement.The AU$6 bid implies a take-out multiple of around 20.7x fiscal 2026 earnings-per-share estimates, below the last two broker schemes. The bid supports sector valuations.The investment firm retained its overweight rating on Steadfast Group and raised the price target to AU$5.90 from AU$5.65.Steadfast Group's shares shed nearly 2% in recent Thursday trade.

ASX:SDF

Asia28d ago

Aurum Resources Says Ivory Coast Gold Project Prefeasibility Study Confirms Economically Compelling, Large-Scale Open Pit Development

Aurum Resources (ASX:AUE) said the prefeasibility study for its Boundiali gold project in northern Ivory Coast confirmed the project as a technically robust, economically compelling, large-scale open-pit gold development, according to a Thursday Australian bourse filing.It declared a maiden probable ore reserve estimate of 42.1 million tonnes at 0.9 grams per tonne grade of gold for 1.21 million ounces of gold from four open pit deposits, BDT1, BDT2, BMT3, and BST, as of April 30. It also declared around 77% conversion of indicated mineral resources to probable ore reserve.The life-of-mine inventory for the development came at 66.2 million tonnes at 0.82 g/t grade of gold for 1.7 million ounces, with life-of-mine gold production of 1.5 million ounces over 11 years at 86.7% recovery.Its shares fell 2% in recent trading on Thursday.

ASX:AUE

Asia28d ago

Bao Pharma's IND Application Gains US FDA Approval for Bacterial Infection Therapy

Shanghai Bao Pharmaceuticals (HKG:2659) said it has received investigational new drug clearance from the U.S. Food and Drug Administration for subcutaneous infusion of BJ007, according to a Wednesday Hong Kong bourse filing.The clearance enables the company to begin a clinical trial evaluating the pharmacokinetic characteristics, absolute bioavailability, and PK/PD efficacy of BJ007 compared with intravenous ceftriaxone sodium in healthy participants, the filing said.BJ007 is a subcutaneous ceftriaxone sodium candidate being developed for the treatment of bacterial infections.

HKG:2659

Asia28d ago

Novonix Delivers Key Synthetic Graphite C-Sample to Panasonic; Shares Up 15%

Novonix (ASX:NVX) delivered a mass production qualification C-sample of synthetic graphite anode active material to Panasonic Energy, marking a key milestone toward potential commercial supply, according to a Thursday Australian bourse filing.The company said this marks the first known delivery in North America of a synthetic graphite C-sample, per the filing.Internal testing shows the material complies with Panasonic's required specifications, but formal validation has yet to be completed, the filing said.The company expects mass production for Panasonic to begin in the second half of 2027, subject to successful qualification by Panasonic and its customers, reaffirming prior guidance, the filing added.The company's shares rose past 15% in recent Thursday trade.

ASX:NVX

Asia28d ago

EVT Says Velocity Frequent Flyer Launches Partnership with Event Cinemas, Village Cinemas

EVT (ASX:EVT) said Velocity Frequent Flyer launched a partnership with Event Cinemas and Village Cinemas, under which members can earn a Velocity point per eligible AU$1 spent on Velocity movie tickets and candy bar purchases and redeem points instantly using the points + pay system, according to a Thursday statement.Movie tickets are available from 2,000 Velocity points, and the partnership launched at 70 cinema locations and over 600 screens across Australia.Its shares rose 1% in recent trading on Thursday.

ASX:EVT

Asia28d ago

Alphamab Says Phase 3 Study of Breast Cancer Drug Meets Primary Endpoint

Alphamab Oncology (HKG:9966) said a Phase 3 study of Anbenitamab, or KN026, which it co-developed with Shanghai JMT-Bio Technology, a subsidiary of CSPC Pharma (HKG:1093), met its primary endpoint in the first-line treatment of HER2-positive advanced breast cancer, according to a Wednesday bourse filing.The company said KN026, in combination with albumin-bound docetaxel HB1801, significantly improved progression-free survival and reduced the risk of disease progression or death compared with the current standard regimen of trastuzumab, pertuzumab, and docetaxel.The study enrolled about 880 patients and compared KN026 plus HB1801 against the standard treatment regimen in patients with HER2-positive advanced breast cancer.

HKG:1093HKG:9966

Asia28d ago

Veem's Return to 'Meaningful' Growth Unlikely Until Second Half of Fiscal 2027, Euroz Hartleys Says

Veem's (ASX:VEE) return to "meaningful" growth is unlikely to happen until the second half of fiscal 2027, when material contributions from defense opportunities are anticipated, despite the company's guidance suggesting positive exit momentum for fiscal 2026, Euroz Hartleys said in a Wednesday note.The company expects fiscal 2026 revenue of between AU$50 million and AU$52 million, and earnings before interest, taxes, depreciation, and amortization of AU$3.3 million to AU$3.8 million.Trading has improved in the fiscal second half, with stronger defense activity, and a continued recovery in propulsion demand and deliveries to initial Veem Extreme customers, the financial services firm said.The company also completed its factory extension construction, securing 1,000 square meters of additional manufacturing space.Euroz Hartleys reaffirmed its speculative buy recommendation and AU$1 price target on Veem.Veem's shares jumped nearly 3% in morning trade Thursday.

ASX:VEE

Asia28d ago

Kintor Pharma Posts Positive Interim Safety Data for Whitening Agent KT-939

Kintor Pharmaceutical (HKG:9939) posted positive interim results from a long-term human safety trial of KT-939 and has begun the registration process for the compound as a new cosmetic ingredient in China, according to a Wednesday Hong Kong bourse filing.The company said 119 participants received continuous topical treatment with KT-939 for 28 weeks, with no adverse skin reactions reported.The trial is evaluating the safety of a cosmetic formulation containing 0.2% KT-939 over 52 consecutive weeks and is expected to be completed in September.

HKG:9939

Asia28d ago

Titomic Signs Multi-Year Cooperative Research Agreement With US Military Organization

Titomic (ASX:TTT) said its US unit Titomic USA has signed a cooperative research and development agreement (CRADA) with a US military research organization to establish a multi-year framework for collaborative research activities supporting next-generation defense modernization, sustainment, advanced manufacturing, and materials development, according to a Thursday Australian bourse filing.The company said the agreement establishes a framework for multiple research activities designed to advance the proprietary Titomic Kinetic Fusion (TKF) cold spray technology for military applications that require enhanced survivability, improved readiness, and accelerated manufacturing capability.Through the CRADA, Titomic and the government organization will jointly investigate advanced TKF applications related to repair, restoration, advanced materials development, survivability enhancement, and expeditionary manufacturing, it added.The company's shares fell 2% in recent Thursday trade.

ASX:TTT

Asia28d ago

Frontier Real Estate Investment Secures 2 Billion Yen Short-Term Loan

Frontier Real Estate Investment (TYO:8964) has secured a short-term loan of 2 billion yen from The Bank of Fukuoka to repay existing debt of a similar amount, according to a Tokyo bourse filing on Thursday.The new loan, which carries a fixed interest rate of 1.12691%, is set to be drawn on Thursday, June 11, and mature on July 10.

TYO:8964

Asia28d ago

Synagistics Partners With Mei Ah Entertainment on AI Commerce Brand

Synagistics (HKG:2562) partnered with Mei Ah Entertainment (HKG:0391) to launch MASYN, an AI-powered e-commerce venture targeting consumer brand development and cross-border expansion in Southeast Asia, according to a Thursday Hong Kong bourse filing.The project combines Mei Ah's AI content creation, product development, and supply chain capabilities with Synagistics' AI commerce infrastructure and regional e-commerce operations.MASYN will use AI-generated content, livestream commerce, short-video marketing, and data-driven product testing across digital commerce platforms, including TikTok Shop, to support brand incubation and regional expansion.

HKG:0391HKG:2562

Asia28d ago

3i Infotech to Provide IT Services to Hindustan Petroleum in INR371 Million Purchase Order

3i Infotech (NSE:3IINFOLTD, BOM:532628) has secured a purchase order worth 370.5 million Indian rupees from Hindustan Petroleum Corporation (NSE:HINDPETRO, BOM:500104), according to a Wednesday filing to the Indian stock exchanges.The contract is for providing facility management services across Hindustan Petroleum's locations for three years and supporting its distributed IT operations through managed infrastructure services.The project entails providing IT services to HPCL, including skilled manpower support, desktop and endpoint support, printer and scanner support, server support, VMS endpoint support, travel assistance, and related IT infrastructure support services.

BOM:500104BOM:532628NSE:3IINFOLTDNSE:HINDPETRO

Asia28d ago

Alligator Energy Resumes Drilling at Big Lake Uranium Project in South Australia, Shares Fall 6%

Alligator Energy (ASX:AGE) resumed a follow-up drill program at the Big Lake uranium project in South Australia, following a hiatus caused by persistent rain after initial discovery in 2024, according to a Thursday Australian bourse filing.The company said the Big Lake project encompasses the northern extensions of the proven uranium-bearing sedimentary system that hosts the Beverley, Four Mile, and Honeymoon in-situ recovery (ISR) uranium operations in South Australia.The company's shares fell 6% in recent Thursday trade.

ASX:AGE

Asia28d ago

Hard Off's All-Stores Sales Rise 36% in May

Hard Off's (TYO:2674) all-store sales at its directly operated stores jumped 36% in May from a year earlier, according to a Wednesday filing on the Tokyo Stock Exchange.The second-hand goods retailer's existing-store sales increased by nearly 13% during the month.The company operated 1,086 stores at the end of March, spanning domestic and overseas locations.

TYO:2674

Asia28d ago

Market Chatter: SK Hynix to Raise Wafer Capacity by Three Times by 2034: SK Group Chairman

SK Hynix (KRX:000660) plans to raise its wafer capacity by three times by 2034 to keep up with the increasing demand for memory chips needed for AI computing, SK Group Chairman Chey Tae-won told Nikkei Asia in an interview on Wednesday.The chipmaker is currently building four semiconductor fabrication plants in South Korea's Yongin, with the first facility expected to be completed in early 2027. Chey said the company accelerated the project timeline by a decade, bringing forth a plan that was initially expected to run till 2045, the report said.Shares of SK Hynix fell over 2% in recent trade on Thursday.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

KRX:000660

Asia28d ago

Northern Star Resources Does Not Understand Magnitude of Required Change, Elliott Says

Northern Star Resources' (ASX:NST) board has formally acknowledged the company's underperformance, but a recent letter to shareholders suggests it "does not understand the magnitude of change required" to regain their trust, activist investor Elliott Investment Management said Thursday.Elliott, which earlier disclosed a stake of more than AU$1 billion in Northern Star, is pushing the company to launch a strategic review that includes a potential sale, and strengthen its board.In response to Elliott's initial outreach, Northern Star Chairman Michael Chaney said the company has been approached by various parties over a possible corporate combination, but it is not the right time to pursue a sale process."The board cannot simultaneously acknowledge inbound corporate interest, confirm its advisers have modeled structural options, and then decline to run any kind of formal process," Elliott said. "The case for a strategic review is now more apparent than it was before the board published its letter."The activist investor believes Northern Star must move immediately to restore shareholder value by bolstering its board and launching a formal strategic review of alternatives."No options should be taken off the table, and no outcome should be prejudged," it said.Northern Star Resources did not immediately reply to a request for comment from.The company's shares declined 2% in recent Thursday trade.

ASX:NST

Showing 4921-4940 of 16858